nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—PTGS1—kidney cancer	0.254	0.673	CbGaD
Eletriptan—ABCB1—kidney cancer	0.123	0.327	CbGaD
Eletriptan—HTR2B—Sorafenib—kidney cancer	0.0451	0.112	CbGbCtD
Eletriptan—ABCB1—Temsirolimus—kidney cancer	0.0306	0.0764	CbGbCtD
Eletriptan—CYP2D6—Temsirolimus—kidney cancer	0.0288	0.072	CbGbCtD
Eletriptan—CYP3A4—Everolimus—kidney cancer	0.0272	0.0678	CbGbCtD
Eletriptan—CYP3A4—Temsirolimus—kidney cancer	0.0183	0.0458	CbGbCtD
Eletriptan—CYP2C9—Capecitabine—kidney cancer	0.0173	0.0432	CbGbCtD
Eletriptan—ABCB1—Pazopanib—kidney cancer	0.0161	0.0402	CbGbCtD
Eletriptan—CYP2D6—Pazopanib—kidney cancer	0.0152	0.0378	CbGbCtD
Eletriptan—ABCB1—Dactinomycin—kidney cancer	0.0147	0.0367	CbGbCtD
Eletriptan—ABCB1—Gemcitabine—kidney cancer	0.0116	0.029	CbGbCtD
Eletriptan—CYP2C19—Sorafenib—kidney cancer	0.0116	0.0289	CbGbCtD
Eletriptan—ABCB1—Erlotinib—kidney cancer	0.0115	0.0287	CbGbCtD
Eletriptan—CYP2C9—Paclitaxel—kidney cancer	0.0108	0.027	CbGbCtD
Eletriptan—CYP2D6—Erlotinib—kidney cancer	0.0108	0.027	CbGbCtD
Eletriptan—ABCB1—Paclitaxel—kidney cancer	0.0105	0.0262	CbGbCtD
Eletriptan—CYP3A4—Pazopanib—kidney cancer	0.00964	0.0241	CbGbCtD
Eletriptan—CYP2C9—Sorafenib—kidney cancer	0.00962	0.024	CbGbCtD
Eletriptan—ABCB1—Sorafenib—kidney cancer	0.00933	0.0233	CbGbCtD
Eletriptan—ABCB1—Vinblastine—kidney cancer	0.00921	0.023	CbGbCtD
Eletriptan—ABCB1—Vincristine—kidney cancer	0.00906	0.0226	CbGbCtD
Eletriptan—CYP2D6—Sorafenib—kidney cancer	0.00879	0.0219	CbGbCtD
Eletriptan—CYP2D6—Vinblastine—kidney cancer	0.00868	0.0217	CbGbCtD
Eletriptan—ABCB1—Sunitinib—kidney cancer	0.00756	0.0189	CbGbCtD
Eletriptan—CYP3A4—Erlotinib—kidney cancer	0.00688	0.0172	CbGbCtD
Eletriptan—CYP3A4—Paclitaxel—kidney cancer	0.00629	0.0157	CbGbCtD
Eletriptan—ABCB1—Doxorubicin—kidney cancer	0.00566	0.0141	CbGbCtD
Eletriptan—CYP3A4—Sorafenib—kidney cancer	0.00559	0.014	CbGbCtD
Eletriptan—CYP3A4—Vinblastine—kidney cancer	0.00552	0.0138	CbGbCtD
Eletriptan—CYP3A4—Vincristine—kidney cancer	0.00543	0.0135	CbGbCtD
Eletriptan—CYP2D6—Doxorubicin—kidney cancer	0.00534	0.0133	CbGbCtD
Eletriptan—CYP3A4—Sunitinib—kidney cancer	0.00453	0.0113	CbGbCtD
Eletriptan—CYP3A4—Doxorubicin—kidney cancer	0.00339	0.00847	CbGbCtD
Eletriptan—CYP2C19—urine—kidney cancer	0.000482	0.165	CbGeAlD
Eletriptan—CYP2C9—urine—kidney cancer	0.000374	0.128	CbGeAlD
Eletriptan—CYP3A4—urine—kidney cancer	0.000285	0.0974	CbGeAlD
Eletriptan—CYP2D6—urine—kidney cancer	0.00028	0.0958	CbGeAlD
Eletriptan—HTR1D—kidney—kidney cancer	0.000147	0.0501	CbGeAlD
Eletriptan—HTR2B—cortex of kidney—kidney cancer	0.000133	0.0454	CbGeAlD
Eletriptan—HTR1A—renal system—kidney cancer	0.000126	0.0432	CbGeAlD
Eletriptan—HTR7—renal system—kidney cancer	0.000121	0.0413	CbGeAlD
Eletriptan—HTR7—kidney—kidney cancer	0.000117	0.0399	CbGeAlD
Eletriptan—HTR7—gonad—kidney cancer	0.000108	0.037	CbGeAlD
Eletriptan—Affect lability—Doxorubicin—kidney cancer	8.6e-05	0.000455	CcSEcCtD
Eletriptan—Nausea—Everolimus—kidney cancer	8.6e-05	0.000454	CcSEcCtD
Eletriptan—Diarrhoea—Sorafenib—kidney cancer	8.6e-05	0.000454	CcSEcCtD
Eletriptan—Hypertension—Paclitaxel—kidney cancer	8.59e-05	0.000454	CcSEcCtD
Eletriptan—Pruritus—Sunitinib—kidney cancer	8.55e-05	0.000452	CcSEcCtD
Eletriptan—Immune system disorder—Capecitabine—kidney cancer	8.47e-05	0.000448	CcSEcCtD
Eletriptan—Myalgia—Paclitaxel—kidney cancer	8.47e-05	0.000448	CcSEcCtD
Eletriptan—Arthralgia—Paclitaxel—kidney cancer	8.47e-05	0.000448	CcSEcCtD
Eletriptan—Anxiety—Paclitaxel—kidney cancer	8.44e-05	0.000446	CcSEcCtD
Eletriptan—Face oedema—Doxorubicin—kidney cancer	8.44e-05	0.000446	CcSEcCtD
Eletriptan—Decreased appetite—Gemcitabine—kidney cancer	8.43e-05	0.000446	CcSEcCtD
Eletriptan—Hypersensitivity—Dactinomycin—kidney cancer	8.43e-05	0.000445	CcSEcCtD
Eletriptan—Chills—Capecitabine—kidney cancer	8.42e-05	0.000445	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	8.41e-05	0.000445	CcSEcCtD
Eletriptan—Arrhythmia—Capecitabine—kidney cancer	8.38e-05	0.000443	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Gemcitabine—kidney cancer	8.38e-05	0.000442	CcSEcCtD
Eletriptan—Discomfort—Paclitaxel—kidney cancer	8.37e-05	0.000442	CcSEcCtD
Eletriptan—Fatigue—Gemcitabine—kidney cancer	8.36e-05	0.000442	CcSEcCtD
Eletriptan—Gastrointestinal pain—Vincristine—kidney cancer	8.36e-05	0.000442	CcSEcCtD
Eletriptan—PTGS1—renal system—kidney cancer	8.35e-05	0.0285	CbGeAlD
Eletriptan—Dizziness—Sorafenib—kidney cancer	8.31e-05	0.000439	CcSEcCtD
Eletriptan—Pain—Gemcitabine—kidney cancer	8.3e-05	0.000438	CcSEcCtD
Eletriptan—Constipation—Gemcitabine—kidney cancer	8.3e-05	0.000438	CcSEcCtD
Eletriptan—Nausea—Erlotinib—kidney cancer	8.3e-05	0.000438	CcSEcCtD
Eletriptan—Alopecia—Capecitabine—kidney cancer	8.29e-05	0.000438	CcSEcCtD
Eletriptan—Dry mouth—Paclitaxel—kidney cancer	8.29e-05	0.000438	CcSEcCtD
Eletriptan—Mood swings—Doxorubicin—kidney cancer	8.28e-05	0.000437	CcSEcCtD
Eletriptan—Diarrhoea—Sunitinib—kidney cancer	8.27e-05	0.000437	CcSEcCtD
Eletriptan—Ataxia—Doxorubicin—kidney cancer	8.22e-05	0.000434	CcSEcCtD
Eletriptan—Asthenia—Dactinomycin—kidney cancer	8.21e-05	0.000434	CcSEcCtD
Eletriptan—Confusional state—Paclitaxel—kidney cancer	8.19e-05	0.000433	CcSEcCtD
Eletriptan—Oedema—Paclitaxel—kidney cancer	8.12e-05	0.000429	CcSEcCtD
Eletriptan—Abdominal pain—Vincristine—kidney cancer	8.08e-05	0.000427	CcSEcCtD
Eletriptan—Body temperature increased—Vincristine—kidney cancer	8.08e-05	0.000427	CcSEcCtD
Eletriptan—Liver function test abnormal—Doxorubicin—kidney cancer	8.07e-05	0.000426	CcSEcCtD
Eletriptan—PTGS1—kidney—kidney cancer	8.07e-05	0.0276	CbGeAlD
Eletriptan—Flatulence—Capecitabine—kidney cancer	8.05e-05	0.000425	CcSEcCtD
Eletriptan—Dry skin—Doxorubicin—kidney cancer	8.01e-05	0.000423	CcSEcCtD
Eletriptan—Dysgeusia—Capecitabine—kidney cancer	8e-05	0.000423	CcSEcCtD
Eletriptan—Dizziness—Sunitinib—kidney cancer	8e-05	0.000422	CcSEcCtD
Eletriptan—Feeling abnormal—Gemcitabine—kidney cancer	7.99e-05	0.000422	CcSEcCtD
Eletriptan—Shock—Paclitaxel—kidney cancer	7.99e-05	0.000422	CcSEcCtD
Eletriptan—Vomiting—Sorafenib—kidney cancer	7.99e-05	0.000422	CcSEcCtD
Eletriptan—Abdominal pain upper—Doxorubicin—kidney cancer	7.98e-05	0.000422	CcSEcCtD
Eletriptan—Nervous system disorder—Paclitaxel—kidney cancer	7.97e-05	0.000421	CcSEcCtD
Eletriptan—Tachycardia—Paclitaxel—kidney cancer	7.93e-05	0.000419	CcSEcCtD
Eletriptan—Rash—Sorafenib—kidney cancer	7.92e-05	0.000419	CcSEcCtD
Eletriptan—Dermatitis—Sorafenib—kidney cancer	7.92e-05	0.000418	CcSEcCtD
Eletriptan—Back pain—Capecitabine—kidney cancer	7.9e-05	0.000417	CcSEcCtD
Eletriptan—Skin disorder—Paclitaxel—kidney cancer	7.89e-05	0.000417	CcSEcCtD
Eletriptan—Headache—Sorafenib—kidney cancer	7.87e-05	0.000416	CcSEcCtD
Eletriptan—Muscle spasms—Capecitabine—kidney cancer	7.85e-05	0.000415	CcSEcCtD
Eletriptan—Hyperhidrosis—Paclitaxel—kidney cancer	7.85e-05	0.000415	CcSEcCtD
Eletriptan—Diarrhoea—Dactinomycin—kidney cancer	7.83e-05	0.000414	CcSEcCtD
Eletriptan—Anorexia—Paclitaxel—kidney cancer	7.74e-05	0.000409	CcSEcCtD
Eletriptan—Gastritis—Doxorubicin—kidney cancer	7.74e-05	0.000409	CcSEcCtD
Eletriptan—Muscular weakness—Doxorubicin—kidney cancer	7.71e-05	0.000407	CcSEcCtD
Eletriptan—Vomiting—Sunitinib—kidney cancer	7.69e-05	0.000406	CcSEcCtD
Eletriptan—Body temperature increased—Gemcitabine—kidney cancer	7.67e-05	0.000405	CcSEcCtD
Eletriptan—Tremor—Capecitabine—kidney cancer	7.65e-05	0.000404	CcSEcCtD
Eletriptan—Rash—Sunitinib—kidney cancer	7.62e-05	0.000403	CcSEcCtD
Eletriptan—Dermatitis—Sunitinib—kidney cancer	7.62e-05	0.000402	CcSEcCtD
Eletriptan—Abdominal distension—Doxorubicin—kidney cancer	7.61e-05	0.000402	CcSEcCtD
Eletriptan—Hypotension—Paclitaxel—kidney cancer	7.59e-05	0.000401	CcSEcCtD
Eletriptan—Ill-defined disorder—Capecitabine—kidney cancer	7.58e-05	0.0004	CcSEcCtD
Eletriptan—Headache—Sunitinib—kidney cancer	7.57e-05	0.0004	CcSEcCtD
Eletriptan—Dysphagia—Doxorubicin—kidney cancer	7.56e-05	0.000399	CcSEcCtD
Eletriptan—Influenza—Doxorubicin—kidney cancer	7.56e-05	0.000399	CcSEcCtD
Eletriptan—Asthma—Doxorubicin—kidney cancer	7.56e-05	0.000399	CcSEcCtD
Eletriptan—Anaemia—Capecitabine—kidney cancer	7.55e-05	0.000399	CcSEcCtD
Eletriptan—Hypersensitivity—Vincristine—kidney cancer	7.53e-05	0.000398	CcSEcCtD
Eletriptan—PTGS1—cardiac atrium—kidney cancer	7.47e-05	0.0255	CbGeAlD
Eletriptan—Nausea—Sorafenib—kidney cancer	7.46e-05	0.000394	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Paclitaxel—kidney cancer	7.4e-05	0.000391	CcSEcCtD
Eletriptan—Malaise—Capecitabine—kidney cancer	7.37e-05	0.000389	CcSEcCtD
Eletriptan—Angina pectoris—Doxorubicin—kidney cancer	7.36e-05	0.000389	CcSEcCtD
Eletriptan—Insomnia—Paclitaxel—kidney cancer	7.35e-05	0.000388	CcSEcCtD
Eletriptan—Vertigo—Capecitabine—kidney cancer	7.34e-05	0.000388	CcSEcCtD
Eletriptan—Asthenia—Vincristine—kidney cancer	7.34e-05	0.000388	CcSEcCtD
Eletriptan—Syncope—Capecitabine—kidney cancer	7.32e-05	0.000387	CcSEcCtD
Eletriptan—Leukopenia—Capecitabine—kidney cancer	7.31e-05	0.000386	CcSEcCtD
Eletriptan—Paraesthesia—Paclitaxel—kidney cancer	7.29e-05	0.000385	CcSEcCtD
Eletriptan—Vomiting—Dactinomycin—kidney cancer	7.28e-05	0.000384	CcSEcCtD
Eletriptan—Bronchitis—Doxorubicin—kidney cancer	7.27e-05	0.000384	CcSEcCtD
Eletriptan—Dyspnoea—Paclitaxel—kidney cancer	7.24e-05	0.000383	CcSEcCtD
Eletriptan—Somnolence—Paclitaxel—kidney cancer	7.22e-05	0.000381	CcSEcCtD
Eletriptan—Palpitations—Capecitabine—kidney cancer	7.22e-05	0.000381	CcSEcCtD
Eletriptan—Rash—Dactinomycin—kidney cancer	7.22e-05	0.000381	CcSEcCtD
Eletriptan—Nausea—Sunitinib—kidney cancer	7.18e-05	0.000379	CcSEcCtD
Eletriptan—Loss of consciousness—Capecitabine—kidney cancer	7.18e-05	0.000379	CcSEcCtD
Eletriptan—Dyspepsia—Paclitaxel—kidney cancer	7.15e-05	0.000378	CcSEcCtD
Eletriptan—Cough—Capecitabine—kidney cancer	7.13e-05	0.000376	CcSEcCtD
Eletriptan—Decreased appetite—Paclitaxel—kidney cancer	7.06e-05	0.000373	CcSEcCtD
Eletriptan—Hypertension—Capecitabine—kidney cancer	7.05e-05	0.000372	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Paclitaxel—kidney cancer	7.01e-05	0.00037	CcSEcCtD
Eletriptan—Fatigue—Paclitaxel—kidney cancer	7e-05	0.00037	CcSEcCtD
Eletriptan—Diarrhoea—Vincristine—kidney cancer	7e-05	0.00037	CcSEcCtD
Eletriptan—Pollakiuria—Doxorubicin—kidney cancer	6.98e-05	0.000369	CcSEcCtD
Eletriptan—CYP3A4—renal system—kidney cancer	6.97e-05	0.0238	CbGeAlD
Eletriptan—Asthenia—Gemcitabine—kidney cancer	6.96e-05	0.000368	CcSEcCtD
Eletriptan—Arthralgia—Capecitabine—kidney cancer	6.95e-05	0.000367	CcSEcCtD
Eletriptan—Myalgia—Capecitabine—kidney cancer	6.95e-05	0.000367	CcSEcCtD
Eletriptan—Constipation—Paclitaxel—kidney cancer	6.95e-05	0.000367	CcSEcCtD
Eletriptan—Pain—Paclitaxel—kidney cancer	6.95e-05	0.000367	CcSEcCtD
Eletriptan—Anxiety—Capecitabine—kidney cancer	6.93e-05	0.000366	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	6.91e-05	0.000365	CcSEcCtD
Eletriptan—Weight increased—Doxorubicin—kidney cancer	6.88e-05	0.000363	CcSEcCtD
Eletriptan—Discomfort—Capecitabine—kidney cancer	6.87e-05	0.000363	CcSEcCtD
Eletriptan—Pruritus—Gemcitabine—kidney cancer	6.86e-05	0.000363	CcSEcCtD
Eletriptan—CYP2D6—renal system—kidney cancer	6.86e-05	0.0234	CbGeAlD
Eletriptan—Weight decreased—Doxorubicin—kidney cancer	6.84e-05	0.000361	CcSEcCtD
Eletriptan—Hyperglycaemia—Doxorubicin—kidney cancer	6.82e-05	0.00036	CcSEcCtD
Eletriptan—Dry mouth—Capecitabine—kidney cancer	6.8e-05	0.000359	CcSEcCtD
Eletriptan—Nausea—Dactinomycin—kidney cancer	6.8e-05	0.000359	CcSEcCtD
Eletriptan—Dizziness—Vincristine—kidney cancer	6.76e-05	0.000357	CcSEcCtD
Eletriptan—CYP3A4—kidney—kidney cancer	6.74e-05	0.023	CbGeAlD
Eletriptan—Drowsiness—Doxorubicin—kidney cancer	6.74e-05	0.000356	CcSEcCtD
Eletriptan—Confusional state—Capecitabine—kidney cancer	6.72e-05	0.000355	CcSEcCtD
Eletriptan—Feeling abnormal—Paclitaxel—kidney cancer	6.69e-05	0.000354	CcSEcCtD
Eletriptan—Oedema—Capecitabine—kidney cancer	6.67e-05	0.000352	CcSEcCtD
Eletriptan—Gastrointestinal pain—Paclitaxel—kidney cancer	6.64e-05	0.000351	CcSEcCtD
Eletriptan—Diarrhoea—Gemcitabine—kidney cancer	6.64e-05	0.000351	CcSEcCtD
Eletriptan—CYP2D6—kidney—kidney cancer	6.63e-05	0.0227	CbGeAlD
Eletriptan—Neuropathy peripheral—Doxorubicin—kidney cancer	6.6e-05	0.000349	CcSEcCtD
Eletriptan—Stomatitis—Doxorubicin—kidney cancer	6.57e-05	0.000347	CcSEcCtD
Eletriptan—Shock—Capecitabine—kidney cancer	6.56e-05	0.000346	CcSEcCtD
Eletriptan—Conjunctivitis—Doxorubicin—kidney cancer	6.55e-05	0.000346	CcSEcCtD
Eletriptan—Nervous system disorder—Capecitabine—kidney cancer	6.54e-05	0.000345	CcSEcCtD
Eletriptan—Tachycardia—Capecitabine—kidney cancer	6.51e-05	0.000344	CcSEcCtD
Eletriptan—Vomiting—Vincristine—kidney cancer	6.5e-05	0.000343	CcSEcCtD
Eletriptan—Skin disorder—Capecitabine—kidney cancer	6.47e-05	0.000342	CcSEcCtD
Eletriptan—Sweating—Doxorubicin—kidney cancer	6.46e-05	0.000341	CcSEcCtD
Eletriptan—Urticaria—Paclitaxel—kidney cancer	6.45e-05	0.000341	CcSEcCtD
Eletriptan—Rash—Vincristine—kidney cancer	6.45e-05	0.000341	CcSEcCtD
Eletriptan—Hyperhidrosis—Capecitabine—kidney cancer	6.44e-05	0.00034	CcSEcCtD
Eletriptan—Dermatitis—Vincristine—kidney cancer	6.44e-05	0.00034	CcSEcCtD
Eletriptan—Body temperature increased—Paclitaxel—kidney cancer	6.42e-05	0.000339	CcSEcCtD
Eletriptan—Abdominal pain—Paclitaxel—kidney cancer	6.42e-05	0.000339	CcSEcCtD
Eletriptan—Headache—Vincristine—kidney cancer	6.41e-05	0.000338	CcSEcCtD
Eletriptan—Epistaxis—Doxorubicin—kidney cancer	6.35e-05	0.000336	CcSEcCtD
Eletriptan—Anorexia—Capecitabine—kidney cancer	6.35e-05	0.000336	CcSEcCtD
Eletriptan—Sinusitis—Doxorubicin—kidney cancer	6.32e-05	0.000334	CcSEcCtD
Eletriptan—Hypotension—Capecitabine—kidney cancer	6.23e-05	0.000329	CcSEcCtD
Eletriptan—Vomiting—Gemcitabine—kidney cancer	6.17e-05	0.000326	CcSEcCtD
Eletriptan—Bradycardia—Doxorubicin—kidney cancer	6.16e-05	0.000325	CcSEcCtD
Eletriptan—Rash—Gemcitabine—kidney cancer	6.12e-05	0.000323	CcSEcCtD
Eletriptan—Dermatitis—Gemcitabine—kidney cancer	6.11e-05	0.000323	CcSEcCtD
Eletriptan—Headache—Gemcitabine—kidney cancer	6.08e-05	0.000321	CcSEcCtD
Eletriptan—Nausea—Vincristine—kidney cancer	6.07e-05	0.000321	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Capecitabine—kidney cancer	6.07e-05	0.000321	CcSEcCtD
Eletriptan—Rhinitis—Doxorubicin—kidney cancer	6.06e-05	0.00032	CcSEcCtD
Eletriptan—Insomnia—Capecitabine—kidney cancer	6.03e-05	0.000318	CcSEcCtD
Eletriptan—Hypoaesthesia—Doxorubicin—kidney cancer	6.02e-05	0.000318	CcSEcCtD
Eletriptan—Pharyngitis—Doxorubicin—kidney cancer	6e-05	0.000317	CcSEcCtD
Eletriptan—Paraesthesia—Capecitabine—kidney cancer	5.99e-05	0.000316	CcSEcCtD
Eletriptan—Hypersensitivity—Paclitaxel—kidney cancer	5.98e-05	0.000316	CcSEcCtD
Eletriptan—Urinary tract disorder—Doxorubicin—kidney cancer	5.97e-05	0.000316	CcSEcCtD
Eletriptan—Oedema peripheral—Doxorubicin—kidney cancer	5.96e-05	0.000315	CcSEcCtD
Eletriptan—Dyspnoea—Capecitabine—kidney cancer	5.94e-05	0.000314	CcSEcCtD
Eletriptan—Urethral disorder—Doxorubicin—kidney cancer	5.93e-05	0.000313	CcSEcCtD
Eletriptan—Dyspepsia—Capecitabine—kidney cancer	5.87e-05	0.00031	CcSEcCtD
Eletriptan—Visual impairment—Doxorubicin—kidney cancer	5.83e-05	0.000308	CcSEcCtD
Eletriptan—Asthenia—Paclitaxel—kidney cancer	5.83e-05	0.000308	CcSEcCtD
Eletriptan—Decreased appetite—Capecitabine—kidney cancer	5.79e-05	0.000306	CcSEcCtD
Eletriptan—Nausea—Gemcitabine—kidney cancer	5.76e-05	0.000304	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Capecitabine—kidney cancer	5.75e-05	0.000304	CcSEcCtD
Eletriptan—Fatigue—Capecitabine—kidney cancer	5.75e-05	0.000304	CcSEcCtD
Eletriptan—Pruritus—Paclitaxel—kidney cancer	5.75e-05	0.000304	CcSEcCtD
Eletriptan—Constipation—Capecitabine—kidney cancer	5.7e-05	0.000301	CcSEcCtD
Eletriptan—Pain—Capecitabine—kidney cancer	5.7e-05	0.000301	CcSEcCtD
Eletriptan—Tinnitus—Doxorubicin—kidney cancer	5.64e-05	0.000298	CcSEcCtD
Eletriptan—Flushing—Doxorubicin—kidney cancer	5.61e-05	0.000297	CcSEcCtD
Eletriptan—Diarrhoea—Paclitaxel—kidney cancer	5.56e-05	0.000294	CcSEcCtD
Eletriptan—Feeling abnormal—Capecitabine—kidney cancer	5.49e-05	0.00029	CcSEcCtD
Eletriptan—Immune system disorder—Doxorubicin—kidney cancer	5.46e-05	0.000289	CcSEcCtD
Eletriptan—Gastrointestinal pain—Capecitabine—kidney cancer	5.45e-05	0.000288	CcSEcCtD
Eletriptan—ABCB1—nephron tubule—kidney cancer	5.43e-05	0.0186	CbGeAlD
Eletriptan—Chills—Doxorubicin—kidney cancer	5.43e-05	0.000287	CcSEcCtD
Eletriptan—Arrhythmia—Doxorubicin—kidney cancer	5.4e-05	0.000285	CcSEcCtD
Eletriptan—Dizziness—Paclitaxel—kidney cancer	5.37e-05	0.000284	CcSEcCtD
Eletriptan—Alopecia—Doxorubicin—kidney cancer	5.34e-05	0.000282	CcSEcCtD
Eletriptan—Urticaria—Capecitabine—kidney cancer	5.3e-05	0.00028	CcSEcCtD
Eletriptan—Abdominal pain—Capecitabine—kidney cancer	5.27e-05	0.000278	CcSEcCtD
Eletriptan—Body temperature increased—Capecitabine—kidney cancer	5.27e-05	0.000278	CcSEcCtD
Eletriptan—Flatulence—Doxorubicin—kidney cancer	5.19e-05	0.000274	CcSEcCtD
Eletriptan—Tension—Doxorubicin—kidney cancer	5.17e-05	0.000273	CcSEcCtD
Eletriptan—Vomiting—Paclitaxel—kidney cancer	5.16e-05	0.000273	CcSEcCtD
Eletriptan—Dysgeusia—Doxorubicin—kidney cancer	5.16e-05	0.000272	CcSEcCtD
Eletriptan—Rash—Paclitaxel—kidney cancer	5.12e-05	0.000271	CcSEcCtD
Eletriptan—Dermatitis—Paclitaxel—kidney cancer	5.12e-05	0.00027	CcSEcCtD
Eletriptan—Nervousness—Doxorubicin—kidney cancer	5.11e-05	0.00027	CcSEcCtD
Eletriptan—Back pain—Doxorubicin—kidney cancer	5.09e-05	0.000269	CcSEcCtD
Eletriptan—Headache—Paclitaxel—kidney cancer	5.09e-05	0.000269	CcSEcCtD
Eletriptan—Muscle spasms—Doxorubicin—kidney cancer	5.06e-05	0.000267	CcSEcCtD
Eletriptan—ABCB1—renal system—kidney cancer	4.93e-05	0.0169	CbGeAlD
Eletriptan—Hypersensitivity—Capecitabine—kidney cancer	4.91e-05	0.000259	CcSEcCtD
Eletriptan—Ill-defined disorder—Doxorubicin—kidney cancer	4.88e-05	0.000258	CcSEcCtD
Eletriptan—Anaemia—Doxorubicin—kidney cancer	4.87e-05	0.000257	CcSEcCtD
Eletriptan—Agitation—Doxorubicin—kidney cancer	4.84e-05	0.000256	CcSEcCtD
Eletriptan—Nausea—Paclitaxel—kidney cancer	4.82e-05	0.000255	CcSEcCtD
Eletriptan—Asthenia—Capecitabine—kidney cancer	4.78e-05	0.000253	CcSEcCtD
Eletriptan—ABCB1—kidney—kidney cancer	4.77e-05	0.0163	CbGeAlD
Eletriptan—Malaise—Doxorubicin—kidney cancer	4.75e-05	0.000251	CcSEcCtD
Eletriptan—Vertigo—Doxorubicin—kidney cancer	4.73e-05	0.00025	CcSEcCtD
Eletriptan—Syncope—Doxorubicin—kidney cancer	4.72e-05	0.000249	CcSEcCtD
Eletriptan—Pruritus—Capecitabine—kidney cancer	4.72e-05	0.000249	CcSEcCtD
Eletriptan—Leukopenia—Doxorubicin—kidney cancer	4.71e-05	0.000249	CcSEcCtD
Eletriptan—Palpitations—Doxorubicin—kidney cancer	4.65e-05	0.000246	CcSEcCtD
Eletriptan—ABCB1—cortex of kidney—kidney cancer	4.65e-05	0.0159	CbGeAlD
Eletriptan—Loss of consciousness—Doxorubicin—kidney cancer	4.63e-05	0.000244	CcSEcCtD
Eletriptan—Cough—Doxorubicin—kidney cancer	4.59e-05	0.000243	CcSEcCtD
Eletriptan—Convulsion—Doxorubicin—kidney cancer	4.56e-05	0.000241	CcSEcCtD
Eletriptan—Diarrhoea—Capecitabine—kidney cancer	4.56e-05	0.000241	CcSEcCtD
Eletriptan—Hypertension—Doxorubicin—kidney cancer	4.55e-05	0.00024	CcSEcCtD
Eletriptan—Myalgia—Doxorubicin—kidney cancer	4.48e-05	0.000237	CcSEcCtD
Eletriptan—Arthralgia—Doxorubicin—kidney cancer	4.48e-05	0.000237	CcSEcCtD
Eletriptan—Anxiety—Doxorubicin—kidney cancer	4.47e-05	0.000236	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	4.45e-05	0.000235	CcSEcCtD
Eletriptan—Discomfort—Doxorubicin—kidney cancer	4.43e-05	0.000234	CcSEcCtD
Eletriptan—ABCB1—gonad—kidney cancer	4.42e-05	0.0151	CbGeAlD
Eletriptan—Dizziness—Capecitabine—kidney cancer	4.41e-05	0.000233	CcSEcCtD
Eletriptan—Dry mouth—Doxorubicin—kidney cancer	4.38e-05	0.000232	CcSEcCtD
Eletriptan—Confusional state—Doxorubicin—kidney cancer	4.33e-05	0.000229	CcSEcCtD
Eletriptan—Oedema—Doxorubicin—kidney cancer	4.3e-05	0.000227	CcSEcCtD
Eletriptan—Vomiting—Capecitabine—kidney cancer	4.24e-05	0.000224	CcSEcCtD
Eletriptan—Shock—Doxorubicin—kidney cancer	4.23e-05	0.000223	CcSEcCtD
Eletriptan—Nervous system disorder—Doxorubicin—kidney cancer	4.21e-05	0.000223	CcSEcCtD
Eletriptan—Rash—Capecitabine—kidney cancer	4.2e-05	0.000222	CcSEcCtD
Eletriptan—Dermatitis—Capecitabine—kidney cancer	4.2e-05	0.000222	CcSEcCtD
Eletriptan—Tachycardia—Doxorubicin—kidney cancer	4.19e-05	0.000222	CcSEcCtD
Eletriptan—Headache—Capecitabine—kidney cancer	4.18e-05	0.000221	CcSEcCtD
Eletriptan—Skin disorder—Doxorubicin—kidney cancer	4.17e-05	0.00022	CcSEcCtD
Eletriptan—Hyperhidrosis—Doxorubicin—kidney cancer	4.15e-05	0.000219	CcSEcCtD
Eletriptan—Anorexia—Doxorubicin—kidney cancer	4.1e-05	0.000216	CcSEcCtD
Eletriptan—Hypotension—Doxorubicin—kidney cancer	4.02e-05	0.000212	CcSEcCtD
Eletriptan—Nausea—Capecitabine—kidney cancer	3.96e-05	0.000209	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Doxorubicin—kidney cancer	3.91e-05	0.000207	CcSEcCtD
Eletriptan—Insomnia—Doxorubicin—kidney cancer	3.89e-05	0.000205	CcSEcCtD
Eletriptan—Paraesthesia—Doxorubicin—kidney cancer	3.86e-05	0.000204	CcSEcCtD
Eletriptan—Dyspnoea—Doxorubicin—kidney cancer	3.83e-05	0.000202	CcSEcCtD
Eletriptan—Somnolence—Doxorubicin—kidney cancer	3.82e-05	0.000202	CcSEcCtD
Eletriptan—Dyspepsia—Doxorubicin—kidney cancer	3.78e-05	0.0002	CcSEcCtD
Eletriptan—Decreased appetite—Doxorubicin—kidney cancer	3.74e-05	0.000197	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Doxorubicin—kidney cancer	3.71e-05	0.000196	CcSEcCtD
Eletriptan—Fatigue—Doxorubicin—kidney cancer	3.7e-05	0.000196	CcSEcCtD
Eletriptan—Constipation—Doxorubicin—kidney cancer	3.67e-05	0.000194	CcSEcCtD
Eletriptan—Pain—Doxorubicin—kidney cancer	3.67e-05	0.000194	CcSEcCtD
Eletriptan—Feeling abnormal—Doxorubicin—kidney cancer	3.54e-05	0.000187	CcSEcCtD
Eletriptan—Gastrointestinal pain—Doxorubicin—kidney cancer	3.51e-05	0.000186	CcSEcCtD
Eletriptan—Urticaria—Doxorubicin—kidney cancer	3.41e-05	0.00018	CcSEcCtD
Eletriptan—Abdominal pain—Doxorubicin—kidney cancer	3.4e-05	0.000179	CcSEcCtD
Eletriptan—Body temperature increased—Doxorubicin—kidney cancer	3.4e-05	0.000179	CcSEcCtD
Eletriptan—Hypersensitivity—Doxorubicin—kidney cancer	3.17e-05	0.000167	CcSEcCtD
Eletriptan—Asthenia—Doxorubicin—kidney cancer	3.08e-05	0.000163	CcSEcCtD
Eletriptan—Pruritus—Doxorubicin—kidney cancer	3.04e-05	0.000161	CcSEcCtD
Eletriptan—Diarrhoea—Doxorubicin—kidney cancer	2.94e-05	0.000155	CcSEcCtD
Eletriptan—Dizziness—Doxorubicin—kidney cancer	2.84e-05	0.00015	CcSEcCtD
Eletriptan—Vomiting—Doxorubicin—kidney cancer	2.73e-05	0.000144	CcSEcCtD
Eletriptan—Rash—Doxorubicin—kidney cancer	2.71e-05	0.000143	CcSEcCtD
Eletriptan—Dermatitis—Doxorubicin—kidney cancer	2.71e-05	0.000143	CcSEcCtD
Eletriptan—Headache—Doxorubicin—kidney cancer	2.69e-05	0.000142	CcSEcCtD
Eletriptan—Nausea—Doxorubicin—kidney cancer	2.55e-05	0.000135	CcSEcCtD
Eletriptan—CYP3A4—Metabolism—LDHB—kidney cancer	5.83e-06	0.000192	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—JUN—kidney cancer	5.83e-06	0.000192	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—APC—kidney cancer	5.81e-06	0.000191	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—KIT—kidney cancer	5.81e-06	0.000191	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CTNNB1—kidney cancer	5.78e-06	0.000191	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—KIT—kidney cancer	5.77e-06	0.00019	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—APC—kidney cancer	5.77e-06	0.00019	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—KDR—kidney cancer	5.76e-06	0.00019	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—SCARB1—kidney cancer	5.74e-06	0.000189	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—RAF1—kidney cancer	5.72e-06	0.000188	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PTGS1—kidney cancer	5.68e-06	0.000187	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—KIT—kidney cancer	5.65e-06	0.000186	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—APC—kidney cancer	5.65e-06	0.000186	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—IL2—kidney cancer	5.65e-06	0.000186	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—PTEN—kidney cancer	5.64e-06	0.000186	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—SCARB1—kidney cancer	5.6e-06	0.000184	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.59e-06	0.000184	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GSTT1—kidney cancer	5.57e-06	0.000184	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ACHE—kidney cancer	5.57e-06	0.000184	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PSMD7—kidney cancer	5.57e-06	0.000184	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—MAPK3—kidney cancer	5.56e-06	0.000183	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PTGS1—kidney cancer	5.54e-06	0.000183	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—POMC—kidney cancer	5.53e-06	0.000182	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—MAPK3—kidney cancer	5.53e-06	0.000182	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ACHE—kidney cancer	5.53e-06	0.000182	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GSTT1—kidney cancer	5.53e-06	0.000182	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—POMC—kidney cancer	5.49e-06	0.000181	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—BRAF—kidney cancer	5.46e-06	0.00018	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PSMD7—kidney cancer	5.44e-06	0.000179	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—BRAF—kidney cancer	5.42e-06	0.000179	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—MAPK3—kidney cancer	5.41e-06	0.000178	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—VEGFA—kidney cancer	5.4e-06	0.000178	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—POMC—kidney cancer	5.38e-06	0.000177	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—BRAF—kidney cancer	5.31e-06	0.000175	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—KIT—kidney cancer	5.31e-06	0.000175	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—APC—kidney cancer	5.31e-06	0.000175	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—MAPK1—kidney cancer	5.29e-06	0.000174	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—BCHE—kidney cancer	5.28e-06	0.000174	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—SCARB1—kidney cancer	5.28e-06	0.000174	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—MAPK1—kidney cancer	5.26e-06	0.000173	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—SCARB1—kidney cancer	5.23e-06	0.000172	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PTGS1—kidney cancer	5.22e-06	0.000172	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—SLC5A5—kidney cancer	5.22e-06	0.000172	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.21e-06	0.000172	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PTGS1—kidney cancer	5.18e-06	0.000171	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—BCHE—kidney cancer	5.15e-06	0.00017	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—MAPK1—kidney cancer	5.15e-06	0.00017	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—IL2—kidney cancer	5.13e-06	0.000169	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PSMD7—kidney cancer	5.12e-06	0.000169	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—MAPK3—kidney cancer	5.11e-06	0.000168	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—VEGFA—kidney cancer	5.09e-06	0.000168	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—SLC5A5—kidney cancer	5.09e-06	0.000168	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—MAPK3—kidney cancer	5.08e-06	0.000167	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PSMD7—kidney cancer	5.08e-06	0.000167	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—PIK3CA—kidney cancer	5.06e-06	0.000167	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CA9—kidney cancer	5.06e-06	0.000167	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—POMC—kidney cancer	5.05e-06	0.000166	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—SLC2A1—kidney cancer	5.04e-06	0.000166	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—PIK3CA—kidney cancer	5.02e-06	0.000166	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—KRAS—kidney cancer	5e-06	0.000165	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—BRAF—kidney cancer	4.99e-06	0.000164	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—KRAS—kidney cancer	4.97e-06	0.000164	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—MYC—kidney cancer	4.97e-06	0.000164	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—PIK3CA—kidney cancer	4.92e-06	0.000162	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—SLC2A1—kidney cancer	4.92e-06	0.000162	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.89e-06	0.000161	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—HIF1A—kidney cancer	4.89e-06	0.000161	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TSC2—kidney cancer	4.87e-06	0.000161	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—KRAS—kidney cancer	4.86e-06	0.00016	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—MAPK1—kidney cancer	4.86e-06	0.00016	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—BCHE—kidney cancer	4.86e-06	0.00016	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—MAPK1—kidney cancer	4.84e-06	0.000159	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—MAPK3—kidney cancer	4.82e-06	0.000159	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—BCHE—kidney cancer	4.81e-06	0.000159	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—SLC5A5—kidney cancer	4.8e-06	0.000158	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—SLC5A5—kidney cancer	4.76e-06	0.000157	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—POMC—kidney cancer	4.73e-06	0.000156	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	4.69e-06	0.000154	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—MYC—kidney cancer	4.68e-06	0.000154	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—KDR—kidney cancer	4.67e-06	0.000154	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—SLC2A1—kidney cancer	4.63e-06	0.000153	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—PIK3CA—kidney cancer	4.62e-06	0.000152	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—PIK3CA—kidney cancer	4.59e-06	0.000151	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—SLC2A1—kidney cancer	4.59e-06	0.000151	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—KRAS—kidney cancer	4.59e-06	0.000151	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—MAPK1—kidney cancer	4.58e-06	0.000151	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—KRAS—kidney cancer	4.57e-06	0.000151	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—PIK3CA—kidney cancer	4.56e-06	0.00015	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—RAF1—kidney cancer	4.56e-06	0.00015	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—RELA—kidney cancer	4.54e-06	0.00015	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—RAF1—kidney cancer	4.53e-06	0.000149	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—ERBB2—kidney cancer	4.51e-06	0.000149	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—RELA—kidney cancer	4.51e-06	0.000149	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—ERBB2—kidney cancer	4.48e-06	0.000148	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—POMC—kidney cancer	4.48e-06	0.000147	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—PIK3CA—kidney cancer	4.47e-06	0.000147	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.46e-06	0.000147	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MTOR—kidney cancer	4.45e-06	0.000147	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—RAF1—kidney cancer	4.43e-06	0.000146	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MTOR—kidney cancer	4.42e-06	0.000146	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—RELA—kidney cancer	4.42e-06	0.000145	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—ERBB2—kidney cancer	4.39e-06	0.000145	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MTOR—kidney cancer	4.33e-06	0.000143	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—KRAS—kidney cancer	4.33e-06	0.000143	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—APC—kidney cancer	4.3e-06	0.000142	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—KIT—kidney cancer	4.3e-06	0.000142	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CRABP1—kidney cancer	4.3e-06	0.000142	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.26e-06	0.00014	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—PIK3CA—kidney cancer	4.22e-06	0.000139	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GSTP1—kidney cancer	4.2e-06	0.000138	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—PIK3CA—kidney cancer	4.2e-06	0.000138	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CDKN1B—kidney cancer	4.18e-06	0.000138	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—RAF1—kidney cancer	4.17e-06	0.000137	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CDKN1B—kidney cancer	4.15e-06	0.000137	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—RELA—kidney cancer	4.15e-06	0.000137	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—MAPK3—kidney cancer	4.12e-06	0.000136	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—ERBB2—kidney cancer	4.12e-06	0.000136	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GSTP1—kidney cancer	4.1e-06	0.000135	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—POMC—kidney cancer	4.1e-06	0.000135	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IL2—kidney cancer	4.09e-06	0.000135	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TP53—kidney cancer	4.08e-06	0.000134	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MTOR—kidney cancer	4.07e-06	0.000134	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CDKN1B—kidney cancer	4.06e-06	0.000134	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IL2—kidney cancer	4.06e-06	0.000134	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—BRAF—kidney cancer	4.05e-06	0.000133	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ITPR2—kidney cancer	4e-06	0.000132	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CCND1—kidney cancer	3.98e-06	0.000131	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ABCB1—kidney cancer	3.98e-06	0.000131	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IL2—kidney cancer	3.98e-06	0.000131	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—PIK3CA—kidney cancer	3.98e-06	0.000131	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—JUN—kidney cancer	3.98e-06	0.000131	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CCND1—kidney cancer	3.96e-06	0.00013	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—JUN—kidney cancer	3.95e-06	0.00013	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CTNNB1—kidney cancer	3.95e-06	0.00013	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—MAPK1—kidney cancer	3.92e-06	0.000129	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CTNNB1—kidney cancer	3.92e-06	0.000129	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.89e-06	0.000128	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CCND1—kidney cancer	3.88e-06	0.000128	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—JUN—kidney cancer	3.87e-06	0.000127	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GSTP1—kidney cancer	3.86e-06	0.000127	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GSTM1—kidney cancer	3.86e-06	0.000127	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TP53—kidney cancer	3.85e-06	0.000127	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PTEN—kidney cancer	3.85e-06	0.000127	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CTNNB1—kidney cancer	3.84e-06	0.000126	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GSTP1—kidney cancer	3.83e-06	0.000126	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PTEN—kidney cancer	3.82e-06	0.000126	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CDKN1B—kidney cancer	3.82e-06	0.000126	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PTGS2—kidney cancer	3.77e-06	0.000124	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GSTM1—kidney cancer	3.77e-06	0.000124	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—PIK3CA—kidney cancer	3.75e-06	0.000123	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PTEN—kidney cancer	3.74e-06	0.000123	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IL2—kidney cancer	3.74e-06	0.000123	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—KRAS—kidney cancer	3.7e-06	0.000122	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CYP1A1—kidney cancer	3.66e-06	0.000121	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ABCB1—kidney cancer	3.66e-06	0.000121	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ACHE—kidney cancer	3.64e-06	0.00012	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GSTT1—kidney cancer	3.64e-06	0.00012	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CCND1—kidney cancer	3.64e-06	0.00012	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—JUN—kidney cancer	3.63e-06	0.00012	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ABCB1—kidney cancer	3.63e-06	0.000119	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CTNNB1—kidney cancer	3.61e-06	0.000119	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CYP1A1—kidney cancer	3.57e-06	0.000118	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PTGS2—kidney cancer	3.57e-06	0.000118	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GSTM1—kidney cancer	3.55e-06	0.000117	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GSTM1—kidney cancer	3.52e-06	0.000116	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PTEN—kidney cancer	3.51e-06	0.000116	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—VEGFA—kidney cancer	3.47e-06	0.000114	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—VEGFA—kidney cancer	3.45e-06	0.000114	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—SCARB1—kidney cancer	3.45e-06	0.000114	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PTGS1—kidney cancer	3.42e-06	0.000113	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—PIK3CA—kidney cancer	3.4e-06	0.000112	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—VEGFA—kidney cancer	3.38e-06	0.000111	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—RAF1—kidney cancer	3.38e-06	0.000111	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CYP1A1—kidney cancer	3.37e-06	0.000111	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—RELA—kidney cancer	3.36e-06	0.000111	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PSMD7—kidney cancer	3.35e-06	0.00011	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—ERBB2—kidney cancer	3.34e-06	0.00011	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CYP1A1—kidney cancer	3.34e-06	0.00011	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MTOR—kidney cancer	3.3e-06	0.000109	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PTEN—kidney cancer	3.29e-06	0.000108	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MAPK3—kidney cancer	3.29e-06	0.000108	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MAPK3—kidney cancer	3.26e-06	0.000108	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MAPK3—kidney cancer	3.2e-06	0.000105	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MYC—kidney cancer	3.2e-06	0.000105	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MYC—kidney cancer	3.18e-06	0.000105	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—BCHE—kidney cancer	3.17e-06	0.000105	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—VEGFA—kidney cancer	3.17e-06	0.000105	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—SLC5A5—kidney cancer	3.14e-06	0.000103	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MAPK1—kidney cancer	3.13e-06	0.000103	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PTEN—kidney cancer	3.11e-06	0.000103	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MYC—kidney cancer	3.11e-06	0.000102	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MAPK1—kidney cancer	3.11e-06	0.000102	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CDKN1B—kidney cancer	3.1e-06	0.000102	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MAPK1—kidney cancer	3.04e-06	0.0001	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL2—kidney cancer	3.03e-06	9.98e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.03e-06	9.98e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.01e-06	9.91e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MAPK3—kidney cancer	3e-06	9.89e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—KRAS—kidney cancer	2.95e-06	9.73e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CCND1—kidney cancer	2.95e-06	9.73e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—JUN—kidney cancer	2.95e-06	9.71e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—KRAS—kidney cancer	2.93e-06	9.67e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CTNNB1—kidney cancer	2.92e-06	9.63e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MYC—kidney cancer	2.92e-06	9.62e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—KRAS—kidney cancer	2.87e-06	9.47e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MAPK1—kidney cancer	2.86e-06	9.41e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PTEN—kidney cancer	2.85e-06	9.39e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.74e-06	9.03e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—POMC—kidney cancer	2.73e-06	8.99e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PIK3CA—kidney cancer	2.71e-06	8.94e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—KRAS—kidney cancer	2.7e-06	8.89e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PIK3CA—kidney cancer	2.7e-06	8.88e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—POMC—kidney cancer	2.66e-06	8.77e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PIK3CA—kidney cancer	2.64e-06	8.7e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TP53—kidney cancer	2.62e-06	8.65e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TP53—kidney cancer	2.61e-06	8.59e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—VEGFA—kidney cancer	2.57e-06	8.48e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TP53—kidney cancer	2.55e-06	8.41e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GSTP1—kidney cancer	2.53e-06	8.32e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—POMC—kidney cancer	2.51e-06	8.27e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—POMC—kidney cancer	2.49e-06	8.2e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PIK3CA—kidney cancer	2.48e-06	8.17e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MAPK3—kidney cancer	2.44e-06	8.02e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TP53—kidney cancer	2.4e-06	7.9e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ABCB1—kidney cancer	2.39e-06	7.88e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MYC—kidney cancer	2.37e-06	7.8e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PIK3CA—kidney cancer	2.32e-06	7.65e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GSTM1—kidney cancer	2.32e-06	7.65e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MAPK1—kidney cancer	2.32e-06	7.63e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.2e-06	7.25e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PIK3CA—kidney cancer	2.2e-06	7.24e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—KRAS—kidney cancer	2.19e-06	7.21e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PTGS2—kidney cancer	2.18e-06	7.17e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PTGS2—kidney cancer	2.12e-06	7e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PIK3CA—kidney cancer	2.01e-06	6.62e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PTGS2—kidney cancer	2e-06	6.6e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PTGS2—kidney cancer	1.98e-06	6.54e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TP53—kidney cancer	1.95e-06	6.41e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PTEN—kidney cancer	1.9e-06	6.25e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PTEN—kidney cancer	1.85e-06	6.1e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PTEN—kidney cancer	1.75e-06	5.75e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PTEN—kidney cancer	1.73e-06	5.7e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—POMC—kidney cancer	1.64e-06	5.41e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.34e-06	4.41e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PTGS2—kidney cancer	1.31e-06	4.31e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PIK3CA—kidney cancer	1.31e-06	4.31e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.23e-06	4.06e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.22e-06	4.02e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PTEN—kidney cancer	1.14e-06	3.76e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PIK3CA—kidney cancer	8.05e-07	2.65e-05	CbGpPWpGaD
